PRNewswire | May 16, 2023
Global technology and software company Emerson has been chosen by Syzygy Plasmonics to automate its innovative catalyst reactor technology that uses light instead of thermal energy, such as heat generated from burning fossil fuels, for chemical manufacturing. The all-electric production method is designed to replace fossil fuel-based combustion, helping reduce industrial greenhouse gas emissions and operational costs while advancing global sustainability goals. Syzygy estimates its reactor systems could eliminate 1 gigaton of CO2 emissions by 2040.
The Syzygy catalyst reactor technology will advance decarbonization in a cost-effective way by electrifying carbon-intensive activities such as chemical manufacturing and reducing the carbon intensity of hydrogen, methanol and fuel production. Rather than rely on thermal energy, the Syzygy reactor harnesses the power of light to energize chemical reactions and reduce the carbon footprint in transportation fuels.
"We are excited to advance this opportunity with Emerson not only for its automation technologies and software but also its sustainability leadership and domain expertise in chemical engineering, electrification and hydrogen production," said Syzygy Chief Executive Officer Trevor Best. "As we expand beyond traditional paradigms of reactor technology and launch a new way to electrify chemical manufacturing, we wanted a technology partner who can help us scale our technology efficiently, safely and reliably."
"Emerson is excited to collaborate with Syzygy Plasmonics on such promising technology that could have a significant impact on industries that are some of the most challenging to decarbonize," said Peter Zornio, chief technology officer at Emerson. "This aligns with Emerson's culture of innovation that takes on our customers' biggest challenges."
Syzygy has developed, scaled and integrated its core technologies, incubated at Rice University, into a universal photocatalytic reactor platform, which includes the Rigel™ photoreactor and the proprietary photocatalyst that enables light-driven chemical reactions at unprecedented efficiency.
For the Syzygy modular reactors, Emerson will provide hardware, software and services, including its DeltaV™ distributed control system, industrial software for process simulation and data analytics; Rosemount instrumentation to measure pressure, temperature, level and flow; and Fisher™ valves to control pressure and improve safety.
Syzygy has received funding from the U.S. Department of Energy and the National Science Foundation and investments from Aramco Ventures, BP, Chevron Technology Ventures, Equinor Ventures, EVOK Innovations, Goose Capital, Horizons Ventures, LOTTE Chemical, LOTTE Fine Chemical, Pan American Energy, Sumitomo Corporation of Americas, The Engine and Toyota Ventures.
Syzygy has three field trials planned for 2023. Leading global partners are driving strong market interest with trials located in North Carolina, California and South Korea.
Syzygy Plasmonics is a deep-decarbonization company. It builds reactors that use light instead of combustion to electrify chemical manufacturing and power a cleaner, safer world. Utilizing technology licensed from Rice University and advanced engineering, Syzygy is commercializing a universal photocatalytic reactor platform. When powered with renewable electricity, this tunable technology is designed to reduce both cost and emissions from many different chemical reactions.
CHEMICAL MANAGEMENT, PRODUCTS AND TECHNOLOGIES
PIC Group, Inc. | March 14, 2023
PIC Group, a leading provider of power and energy service across the world, announced being awarded the Operation and Maintenance (O&M) Agreement by LS Power for the Patriot Hydro Portfolio. Under the provisions of the O&M Agreement, PIC Group will have as operational as well as transitional services responsibility, including full care, control, and custody of the Patriot Hydro Portfolio's day-to-day operations and maintenance services through 2025. The Patriot Hydro Portfolio consists of a fleet of 42 hydroelectric power assets dispersed across 11 states.
Frank Avery, President and CEO at PIC Group, said, "PIC Group's systematic and knowledge-based approach to operations and maintenance adds value to the assets with the objective of meeting or exceeding the shared goals of compliance with all regulations and requirements, performance through high availability and reliability as well as O&M cost management across the Patriot Hydro assets."
(Source – Business Newswire)
"PIC Group's proven track record in successfully managing complex programs and larger portfolios of assets uniquely positions them to support the transition, operate and maintain the Patriot Hydroelectric fleet. We look forward to working with PIC Group with their professional, customer centric approach to operations and maintenance," mentioned Anthony Hammond, Senior Vice President, Head of Asset Management at LS Power.
(Source – Business Newswire)
About PIC Group, Inc.
Established in 1988, PIC Group, Inc. is committed to generating value by offering worldwide energy services to sites on four continents: North America, South America, Asia, and Africa. PIC provides O&M services (care, control, and custody), commissioning and startup, documentation and training, and staffing to the oil and gas, power generation, pulp and paper, petrochemical, and manufacturing industries.
About LS Power
LS Power is a North American power and energy infrastructure development, investment, and operating corporation. Since its establishment in 1990, LS Power has developed, built, operated, or acquired over46,000 MW of power production capacity, including wind, utility-scale solar, natural gas-fired, hydro, and battery energy storage projects, 17,000 MW of which are now operational.
Businesswire | May 05, 2023
We are excited to announce a new partnership between Innovassynth and Actylis, two industry-leading companies offering Custom synthesis, Contract manufacturing and off-the-shelf products to the Pharmaceutical and Life Sciences industry. This collaboration will allow Actylis to add Innovassynth’s portfolio of nucleosides to its range of critical raw materials.
Innovassynth, India, is a Custom Development & Manufacturing Organization (CDMO) and a trusted partner to Pharma & Drug Discovery, Life Sciences, Diagnostics, and Material Science companies worldwide. They have technological expertise and extensive experience in the field of chemistry, and they provide services from development to commercialization of products. Nucleic acid chemistry is one of Innovassynth’s core competencies, and they have gained a reputation for being a reliable commercial manufacturer of Protected Nucleosides, Phosphoramidites, and Reagents. Their range of Nucleosides includes DNA, RNA, LNA, and GalNAc conjugated derivatives and intermediates with various spacers, linkers, and other building blocks. Innovassynth offers end-to-end manufacturing and a transparent supply chain for Phosphoramidites and a variety of nucleic acid reagents, which is a compelling proposition to customers lacking supply chain diversity. Innovassynth also has significant capability in Process R&D, Custom Synthesis, & Contract Manufacturing of Pharma intermediates, Specialty Chemicals, and Organometallics for customers worldwide.
Actylis has a large technical sales team of chemists globally who understand customers’ nucleoside needs and advise on the best solution to their product challenges. Actylis can offer complementary products to the Innovassynth range through its recently acquired GMP manufacturing capabilities in Europe and the US. Actylis provides local and global distribution in the US and Europe through strategically located warehouses, supply chain and sales offices in over ten countries. Actylis can support its customer's development projects through every milestone in the development cycle from R&D to commercial production.
"We are truly excited to partner with Actylis which will synergize our reach and offer our customers a wider range of solutions. Due to its techno commercial expertise, global sales and distribution network, Actylis has emerged as the trusted partner of choice. We are committed to providing high-quality products and services to our customers, and we believe this partnership is a step in the right direction,” said Dr. Hardik Joshipura, Managing Director and Chief Executive Officer of Innovassynth.
Gilles Cottier, Chief Executive Officer of Actylis, said: “We’ve worked with Innovassynth on several projects over the past couple of years and I’m continually impressed with their capabilities and quality management. They have become a critical outsourcing partner as our internal projects scale. Innovossynth’s backward integrated Phosphoramidite supply chain – all originating in India – from key starters to finished product brings unique value to our customers. Bringing the nucleoside offering to market, together, fills key continuity of supply challenge for our customers and reinforces our position as The Partner of Choice.”
Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and Agriscience industries. We offer standard and custom ingredients through our rapidly growing portfolio of GMP and non-GMP facilities worldwide, and further choice through our strong sourcing hub network. This unique hybrid option blending manufacturing and global sourcing, combined with more than 75 years of sourcing and distribution experience makes Actylis the Partner of Choice.